Prognostic importance of molecular-like classification in gastroesophageal junction tumors (Izmir Oncology Group [IZOG] study)

Özlem Özdemir; Asuman Argon; Savaş Yakan; Tarık Salman; Ahmet AlacacIoğlu

doi:10.5114/pjp.2021.114175

eISSN: 2084-9869
ISSN: 1233-9687

Polish Journal of Pathology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2021
vol. 72

Send email

Copy url:

abstract:

Original paper

Prognostic importance of molecular-like classification in gastroesophageal junction tumors (Izmir Oncology Group [IZOG] study)

Özlem Özdemir

¹

,

Asuman Argon

²

,

Savaş Yakan

³

,

Tarık Salman

⁴

,

Ahmet AlacacIoğlu

⁴

Department of Medical Oncology, Izmir Bozyaka Education and Research Hospital, The University of Health Sciences, Turkey
Department of Medical Pathology, Izmir Bozyaka Education and Research Hospital, The University of Health Sciences, Izmir, Turkey
Department of General Surgery, Izmir Bozyaka Education and Research Hospital, The University of Health Sciences, Izmir, Turkey
Department of Medical Oncology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir, Turkey

Pol J Pathol 2021; 73 (4): 315-323

DOI: https://doi.org/10.5114/pjp.2021.114175

Online publish date: 2022/03/08

View full text Get citation

PlumX metrics:

A comprehensive molecular classification was published in 2014 within The Cancer Genome Atlas (TCGA) to guide clinical approaches and treatment strategies. This study aimed to investigate the clinicopathological and prognostic importance of the classification using immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH) to identify potential surrogate markers of molecular changes in gastroesophageal junction (GEJ) adenocarcinomas.

A total of 52 GEJ adenocarcinomas were divided into five groups using IHC with MLH-1, E-cadherin, p53 and CISH with EBER: 1) microsatellite unstable (MSI: negative with MLH-1), 2) genomically stable tumors (GS: positive with p53),

3) chromosomally unstable tumors (CUN: negative with e-cadherin), 4) EBV+ tumors (EBV+: positive with EBER) and 5) unclassifiable (G-NOS: MLH-1 and e-cadherin positive with p53 and negative with EBER).

The largest group consisted of 24 (46.2%) cases of CUN tumors. This group was followed by groups of GS with 14 (26.9%) cases, MSI with 7 (13.5%) cases, and EBV + with 3 (5.8%) cases, respectively. Although this classification was not associated with pathological features, it was found to be closely related to prognosis (p = 0.029). Patients with EBV+ tumors had the longest overall survival, followed by the G-NOS, MSI, CUN, GS groups.

keywords:

gastroesophageal junction adenocarcinoma, molecular classification, The Cancer Genome Atlas, immunohistochemical analysis, chromogenic in situ hybridization

Prognostic importance of molecular-like classification in gastroesophageal junction tumors (Izmir Oncology Group [IZOG] study)

Özlem Özdemir 1 , Asuman Argon 2 , Savaş Yakan 3 , Tarık Salman 4 , Ahmet AlacacIoğlu 4

gastroesophageal junction adenocarcinoma, molecular classification, The Cancer Genome Atlas, immunohistochemical analysis, chromogenic in situ hybridization

Özlem Özdemir

¹

,

Asuman Argon

²

,

Savaş Yakan

³

,

Tarık Salman

⁴

,

Ahmet AlacacIoğlu

⁴